Petitions Process

Starting in July 2026, the Minnesota Office of Cannabis Management (OCM) will open its annual online petition process for the following topics: 

  • Approval of a new medical cannabinoid product 
  • Approval of a new medical delivery method for a cannabinoid product 
  • Approval of a new product category 
  • Approval of the use of a cannabinoid in lower-potency hemp edibles 
  • Approval of the manufacture and use of an artificially derived cannabinoid 
  • Declaration of a cannabinoid nonintoxicating 

Per Minnesota Rules, part 9810.1003, subp. 2, petitions will be accepted during the month of July, specifically between the first and last business day of that month each year. This process is governed by Minnesota Rules, chapter 9810, and Minnesota Statutes, chapter 342.   

More information about the upcoming petitions process will be added to this page soon.  

Legislative changes to the petitions process  

Previously, petitions were accepted from the public for medical cannabis delivery methods and qualifying medical conditions. As a result of legislation signed into law in May 2024, OCM no longer accepts petitions for adding qualified medical conditions effective July 1, 2024. More information about qualifying medical conditions, including the impact of 2024 legislative changes, can be found at qualifying medical conditions. 

Also, as a result of legislation signed into law in May 2024, as well as the adoption of the rules governing Minnesota’s cannabis market in April 2025, the process for new medical cannabis delivery methods now follows the petition process described above. Below is a list of previously approved medical cannabis delivery methods: 

  • Combustion with use of dried raw cannabis 
  • Liquid, including but not limited to oil 
  • Pill 
  • Vaporized delivery method with use of liquid or oil  
  • Topical formulation  
  • Water soluble cannabinoid multiparticulate, including granules, powder, and sprinkles  
  • Orally dissolvable product, including lozenges, gum, mints, buccal tablets, and sublingual tablets  
  • Edible products in the form of gummies and chews